MENLO PARK, Calif.,
Jan. 8, 2015 /PRNewswire/
-- BioPharmX Corporation (OTCQB: BPMX), a biotechnology
company focused on the development of novel drug delivery products
to address unmet needs in large, well-defined and underserved
markets, today announced that Jim
Pekarsky, chief executive officer and co-founder of
BioPharmX, will present at the OneMed Forum SF 2015 Conference on
Monday, January 12 at 3:00 p.m. PST at the Marriott Marquis in San
Francisco.
Mr. Pekarsky will provide an overview of BioPharmX's business
strategy as it pursues bringing novel products to market, including
the company's recent commercial launch of VioletTM
iodine, a new, once-daily pill for relief of premenstrual breast
discomfort. Violet iodine is currently available at Walgreen
Co.'s drugstore.com™ web store and BioPharmX anticipates rolling
out Violet iodine to other large retail chains.
A live and archived webcast of the presentation will be
available on the Investors page of the BioPharmX website at
http://biopharmx.investorroom.com/.
About BioPharmX Corporation
BioPharmX Corporation (OTCQB: BPMX) is a Silicon Valley-based
biotechnology company, which seeks to provide innovative products
through unique, proprietary platform technologies for prescription,
over-the-counter ("OTC"), and supplement applications in the
fast-growing health and wellness markets, including women's health,
dermatology, and otolaryngology (ears, nose & throat). To
learn more about BioPharmX, visit www.BioPharmX.com.
Forward-Looking Statements
Statements in this news release relating to the business of
BioPharmX, which are not historical facts, are "forward-looking
statements." These forward-looking statements may be
identified by words such as "expect," "anticipate," "believe," or
similar expressions that are intended to identify such
forward-looking statements. All forward-looking statements
are expressly qualified in their entirety by this cautionary
statement and the risks and other factors detailed in the company's
filings with the Securities and Exchange Commission (SEC). These
statements are based upon the current expectations and beliefs of
management and are subject to certain risks and uncertainties that
could cause actual results to differ materially from those
described in the forward-looking statements, including the risk
that the commercial launch of Violet iodine is unsuccessful and
that the company is unable to offer Violet iodine through other
retail chains. Given these risks and uncertainties, you are
cautioned not to place undue reliance on such forward-looking
statements. The forward-looking statements included in this
news release are made only as of the date hereof and the company
undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities law.
BioPharmX and Violet are pending trademarks of BioPharmX Inc.
All other brand and product names are trademarks or
registered trademarks of their respective holders.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-corporation-to-present-at-onemed-forum-sf-2015-conference-300017615.html
SOURCE BioPharmX